Since its founding in 2014, the team at Sense Neuro Diagnostics has been heads down hard at work. So please excuse the medical device company for not exactly being a household name.
At least not yet. Today, Sense, which calls Norwood-based HCDC home, is making moves at a seemingly accelerated speed after having spent years on R&D. To list just a few of those latest accolades: It added Jack Kraeutler, former CEO of Meridian Bioscience (NASDAQ: VIVO) and a member of Ohio Third Frontier, to its board. StartUs Insights, an Austrian data science company, named Sense to its global top five list of emerging neurological device startups, the only North American company chosen. And, following strong results from initial pilot studies, clinical trials are now underway on one of two Sense devices, a key step toward commercialization.
Click here to read the complete story.
Story excerpt provided by Cincy Inno.
Written by Liz Engel.
Originally published April 1, 2021.